Chronic Heart Failure in Children: State of the Art and New Perspectives

被引:6
作者
Castaldi, Biagio [1 ]
Cuppini, Elena [1 ]
Fumanelli, Jennifer [1 ]
Di Candia, Angela [1 ,2 ]
Sabatino, Jolanda [1 ,2 ]
Sirico, Domenico [1 ]
Vida, Vladimiro [3 ]
Padalino, Massimo [2 ,3 ]
Di Salvo, Giovanni [1 ,2 ]
机构
[1] Univ Padua, Dept Womens & Childrens Hlth, Pediat Cardiol Unit, I-35122 Padua, Italy
[2] Univ Padua, Pediat Res Inst IRP Citta Speranza, I-35122 Padua, Italy
[3] Univ Padua, Dept Cardio Thorac Sci, Pediat Cardiac Surg Unit, I-35122 Padua, Italy
关键词
heart failure; pediatric heart failure; pharmacotherapy for heart failure; device therapy for chronic heart failure; pulmonary artery banding; PULMONARY-ARTERY; DILATED CARDIOMYOPATHY; INTERNATIONAL-SOCIETY; LUNG-TRANSPLANTATION; SYSTOLIC DYSFUNCTION; THERAPEUTIC STRATEGY; YOUNG-CHILDREN; MANAGEMENT; IVABRADINE; THERAPIES;
D O I
10.3390/jcm12072611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pediatric heart failure (HF) is an important clinical condition with high morbidity and mortality. Compared to adults, pediatric HF shows different etiologies characterized by different physiology, a different clinical course, and deeply different therapeutic approaches. In the last few years, new drugs have been developed and new therapeutic strategies have been proposed with the goal of identifying an individualized treatment regimen. The aim of this article is to review the new potential drugs and non-pharmacological therapies for pediatric heart failure in children.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Advanced Heart Failure Therapies for Adults With Congenital Heart Disease JACC State-of-the-Art Review
    Givertz, Michael M.
    DeFilippis, Ersilia M.
    Landzberg, Michael J.
    Pinney, Sean P.
    Woods, Ronald K.
    Valente, Anne Marie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (18) : 2295 - 2312
  • [32] Cachexia in chronic heart failure: endocrine determinants and treatment perspectives
    Mangner, Norman
    Matsuo, Yae
    Schuler, Gerhard
    Adams, Volker
    ENDOCRINE, 2013, 43 (02) : 253 - 265
  • [33] Cachexia in chronic heart failure: endocrine determinants and treatment perspectives
    Norman Mangner
    Yae Matsuo
    Gerhard Schuler
    Volker Adams
    Endocrine, 2013, 43 : 253 - 265
  • [34] Cardiomyopathy and heart failure in children: anesthetic implications
    Rosenthal, David N.
    Hammer, Gregory B.
    PEDIATRIC ANESTHESIA, 2011, 21 (05) : 577 - 584
  • [35] Does Lowering Heart Rate Improve Outcomes in Children With Dilated Cardiomyopathy and Chronic Heart Failure?
    Lipshultz, Steven E.
    Barach, Paul R.
    Wilkinson, James D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (10) : 1273 - 1275
  • [36] Uric acid and xanthine oxidase: perspectives in chronic heart failure
    Patel, Pawan D.
    Arora, Rohit R.
    ARCHIVES OF MEDICAL SCIENCE, 2008, 4 (03) : 219 - 225
  • [37] New perspectives on heart failure due to myocardial ischaemia
    Fox, KF
    Cowie, MR
    Wood, DA
    Coats, AJS
    Poole-Wilson, PA
    Sutton, GC
    EUROPEAN HEART JOURNAL, 1999, 20 (04) : 256 - 262
  • [38] New perspectives and future directions in the treatment of heart failure
    Pierpaolo Pellicori
    Muhammad Javed Iqbal Khan
    Fraser John Graham
    John G. F. Cleland
    Heart Failure Reviews, 2020, 25 : 147 - 159
  • [39] New perspectives and future directions in the treatment of heart failure
    Pellicori, Pierpaolo
    Khan, Muhammad Javed Iqbal
    Graham, Fraser John
    Cleland, John G. F.
    HEART FAILURE REVIEWS, 2020, 25 (01) : 147 - 159
  • [40] What is new in guidelines for chronic heart failure?
    Ilerigelen, Baris
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2006, 34 (02): : 131 - 136